Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Jenkins

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Cancer Research|September 23, 2003
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumorsChristopher S Hackett, J Graeme Hodgson, Mark E Law, et al.
Journal of Neuro-Oncology|May 24, 2019
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
Journal of Neuro-Oncology|June 6, 2019
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
The Journal of Infection|May 1, 2022
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2Daniel Jiménez, Javier Martínez-Sanz, Talía Sainz, et al.
Brain Pathology (Zurich, Switzerland)|July 4, 2020
Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?Rachael Vaubel, Valentina Zschernack, Quynh T Tran, et al.
Journal of the Royal Society of Medicine|February 28, 2025
Key SARS-CoV-2 testing strategies implemented in the UK: rationale and impactTom Fowler, Chris Kenny, Sarah Tunkel, et al.
Neuro-Oncology|April 15, 2010
Oligodendroglioma cell lines containing t(1;19)(q10;p10)John J P Kelly, Michael D Blough, Owen D M Stechishin, et al.
Frontiers in Genetics|November 8, 2021
SeekFusion - A Clinically Validated Fusion Transcript Detection Pipeline for PCR-Based Next-Generation Sequencing of RNAJagadheshwar Balan, Garrett Jenkinson, Asha Nair, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
GLIOGENE an International Consortium to Understand Familial GliomaBeatrice Malmer, Phyllis Adatto, Georgina Armstrong, et al.
Frontiers in Genetics|October 24, 2012
Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approachDaniel I Jacobs, Kyle M Walsh, Margaret Wrensch, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Cancer Research|September 23, 2003
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumorsChristopher S Hackett, J Graeme Hodgson, Mark E Law, et al.
Journal of Neuro-Oncology|May 24, 2019
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
Journal of Neuro-Oncology|June 6, 2019
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
The Journal of Infection|May 1, 2022
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2Daniel Jiménez, Javier Martínez-Sanz, Talía Sainz, et al.
Brain Pathology (Zurich, Switzerland)|July 4, 2020
Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?Rachael Vaubel, Valentina Zschernack, Quynh T Tran, et al.
Journal of the Royal Society of Medicine|February 28, 2025
Key SARS-CoV-2 testing strategies implemented in the UK: rationale and impactTom Fowler, Chris Kenny, Sarah Tunkel, et al.
Neuro-Oncology|April 15, 2010
Oligodendroglioma cell lines containing t(1;19)(q10;p10)John J P Kelly, Michael D Blough, Owen D M Stechishin, et al.
Frontiers in Genetics|November 8, 2021
SeekFusion - A Clinically Validated Fusion Transcript Detection Pipeline for PCR-Based Next-Generation Sequencing of RNAJagadheshwar Balan, Garrett Jenkinson, Asha Nair, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
GLIOGENE an International Consortium to Understand Familial GliomaBeatrice Malmer, Phyllis Adatto, Georgina Armstrong, et al.
Frontiers in Genetics|October 24, 2012
Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approachDaniel I Jacobs, Kyle M Walsh, Margaret Wrensch, et al.
Pageof 7